Autophagy in malignant transformation and cancer progression
Autophagy plays a key role in the maintenance of cellular homeostasis. In healthy cells,
such a homeostatic activity constitutes a robust barrier against malignant transformation …
such a homeostatic activity constitutes a robust barrier against malignant transformation …
Autophagy: for better or for worse
E Wirawan, TV Berghe, S Lippens, P Agostinis… - Cell research, 2012 - nature.com
Autophagy is a lysosomal degradation pathway that degrades damaged or superfluous cell
components into basic biomolecules, which are then recycled back into the cytosol. In this …
components into basic biomolecules, which are then recycled back into the cytosol. In this …
World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs
TY Chan - Urology, 2005 - goldjournal.net
This 2004 volume in the World Health Organization series on histologic and genetic typing
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells
T Hara, A Takamura, C Kishi, S Iemura… - The Journal of cell …, 2008 - rupress.org
Autophagy is a membrane-mediated intracellular degradation system. The serine/threonine
kinase Atg1 plays an essential role in autophagosome formation. However, the role of the …
kinase Atg1 plays an essential role in autophagosome formation. However, the role of the …
Mitophagy and cancer
AH Chourasia, ML Boland, KF Macleod - Cancer & metabolism, 2015 - Springer
Mitophagy is a selective form of macro-autophagy in which mitochondria are selectively
targeted for degradation in autophagolysosomes. Mitophagy can have the beneficial effect …
targeted for degradation in autophagolysosomes. Mitophagy can have the beneficial effect …
Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis
Autophagy is a conserved cellular process for bulk degradation of intracellular protein and
organelles in lysosomes. In contrast to elegant studies of beclin1 using mouse models and …
organelles in lysosomes. In contrast to elegant studies of beclin1 using mouse models and …
From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression
O Schmidt-Kittler, T Ragg… - Proceedings of the …, 2003 - National Acad Sciences
According to the present view, metastasis marks the end in a sequence of genomic changes
underlying the progression of an epithelial cell to a lethal cancer. Here, we aimed to find out …
underlying the progression of an epithelial cell to a lethal cancer. Here, we aimed to find out …
Selective Estrogen Receptor Modulators: Discrimination of Agonistic versus Antagonistic Activities by Gene Expression Profiling in Breast Cancer Cells
J Frasor, F Stossi, JM Danes, B Komm, CR Lyttle… - Cancer research, 2004 - AACR
Selective estrogen receptor modulators (SERMs) such as tamoxifen are effective in the
treatment of many estrogen receptor-positive breast cancers and have also proven to be …
treatment of many estrogen receptor-positive breast cancers and have also proven to be …
Lifetime risks of common cancers among retinoblastoma survivors
O Fletcher, D Easton, K Anderson… - Journal of the …, 2004 - academic.oup.com
Background: Compared with the general population, carriers of germline mutations in RB1
who survive retinoblastoma (ie, hereditary retinoblastoma survivors) are at increased risk of …
who survive retinoblastoma (ie, hereditary retinoblastoma survivors) are at increased risk of …
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
JI Herschkowitz, X He, C Fan, CM Perou - Breast Cancer Research, 2008 - Springer
Introduction Breast cancers can be classified using whole genome expression into distinct
subtypes that show differences in prognosis. One of these groups, the basal-like subtype, is …
subtypes that show differences in prognosis. One of these groups, the basal-like subtype, is …